Anti-ABCC9/ ABC37/ ATFB12 monoclonal antibody

Anti-ABCC9/ ABC37/ ATFB12 antibody for FACS & in-vivo assay

Target products collectionGo to ABCC9/ABCC9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T02777-Ab-1/ GM-Tg-hg-T02777-Ab-2Anti-Human ABCC9 monoclonal antibodyHuman
GM-Tg-rg-T02777-Ab-1/ GM-Tg-rg-T02777-Ab-2Anti-Rat ABCC9 monoclonal antibodyRat
GM-Tg-mg-T02777-Ab-1/ GM-Tg-mg-T02777-Ab-2Anti-Mouse ABCC9 monoclonal antibodyMouse
GM-Tg-cynog-T02777-Ab-1/ GM-Tg-cynog-T02777-Ab-2Anti-Cynomolgus/ Rhesus macaque ABCC9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T02777-Ab-1/ GM-Tg-felg-T02777-Ab-2Anti-Feline ABCC9 monoclonal antibodyFeline
GM-Tg-cang-T02777-Ab-1/ GM-Tg-cang-T02777-Ab-2Anti-Canine ABCC9 monoclonal antibodyCanine
GM-Tg-bovg-T02777-Ab-1/ GM-Tg-bovg-T02777-Ab-2Anti-Bovine ABCC9 monoclonal antibodyBovine
GM-Tg-equg-T02777-Ab-1/ GM-Tg-equg-T02777-Ab-2Anti-Equine ABCC9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T02777-Ab-1/ GM-Tg-hg-T02777-Ab-2; GM-Tg-rg-T02777-Ab-1/ GM-Tg-rg-T02777-Ab-2;
GM-Tg-mg-T02777-Ab-1/ GM-Tg-mg-T02777-Ab-2; GM-Tg-cynog-T02777-Ab-1/ GM-Tg-cynog-T02777-Ab-2;
GM-Tg-felg-T02777-Ab-1/ GM-Tg-felg-T02777-Ab-2; GM-Tg-cang-T02777-Ab-1/ GM-Tg-cang-T02777-Ab-2;
GM-Tg-bovg-T02777-Ab-1/ GM-Tg-bovg-T02777-Ab-2; GM-Tg-equg-T02777-Ab-1/ GM-Tg-equg-T02777-Ab-2
Products NameAnti-ABCC9 monoclonal antibody
Formatmab
Target NameABCC9
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ABCC9 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ABCC9/ ABC37/ ATFB12 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-T02777
    Target NameABCC9
    Gene ID10060,20928,25560,654489,486638,101096657,100336551,111767477
    Gene Symbol and SynonymsABC37,ABCC9,ATFB12,CANTU,CMD1O,IDMYS,SUR2,SUR2A,SUR2B
    Uniprot AccessionO60706,Q63563
    Uniprot Entry NameABCC9_HUMAN,ABCC9_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000069431
    Target ClassificationN/A

    The target: ABCC9, gene name: ABCC9, also named as ABC37, ATFB12, CANTU, CMD1O, SUR2. The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is thought to form ATP-sensitive potassium channels in cardiac, skeletal, and vascular and non-vascular smooth muscle. Protein structure suggests a role as the drug-binding channel-modulating subunit of the extra-pancreatic ATP-sensitive potassium channels. Mutations in this gene are associated with cardiomyopathy dilated type 1O. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.